Virtu Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Virtu Financial’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$407K	Buy	+113,548	New	+$451K	0.02%	664
2025 Q4	–	Sell	-12,386	Closed	-$40K	–	2135
2025 Q3	$40K	Buy	+12,386	New	+$39K	﹤0.01%	1165
2024 Q1	–	Sell	-11,072	Closed	-$332K	–	1969
2023 Q4	$332K	Buy	+11,072	New	+$244K	0.03%	568
2023 Q3	–	Sell	-14,435	Closed	-$287K	–	1776
2023 Q2	$287K	Buy	+14,435	New	+$292K	0.02%	632
2021 Q1	–	Sell	-4,335	Closed	-$238K	–	1945
2020 Q4	$238K	Buy	+4,335	New	+$158K	0.03%	764
2018 Q1	–	Sell	-10,203	Closed	-$107K	–	2474
2017 Q4	$107K	Buy	+10,203	New	+$101K	0.01%	1900
2017 Q3	–	Sell	-4,043	Closed	-$31K	–	2499
2017 Q2	$31K	Buy	+4,043	New	+$30.1K	﹤0.01%	370

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's RCKT Position: Q1 2026 in Review

Virtu Financial opened a new position in Rocket Pharmaceuticals (RCKT) in Q1 2026: 113,548 shares worth $407K. The stake represents 0.02% of the portfolio and ranks #664 among its holdings. This is a return to the name: Virtu Financial previously reported a position in RCKT as recently as Q3 2025.

Virtu Financial first reported a position in RCKT in Q2 2017 and has held it in 7 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

Virtu Financial held 113,548 shares of Rocket Pharmaceuticals worth $407K as of Q1 2026.
Rocket Pharmaceuticals was a new Virtu Financial position in Q1 2026.
Rocket Pharmaceuticals made up 0.02% of Virtu Financial's portfolio in Q1 2026, its #664 holding.
Virtu Financial first reported a position in Rocket Pharmaceuticals in Q2 2017 and has held it in 7 quarters since.
198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.